Elena Garralda directs VHIO's early drug development unit, running first-in-human trials of ADCs, bispecifics, cell therapies, and immunotherapies.
Role
Director, Early Drug Development Unit (UITM), VHIO
Institution
Specialisms
Phase 1 trialsImmuno-oncologyNovel modalities
Profiles
Pages like this
not linked directly; found by shared links- IdeaAn open engineering platform for academic ADCs and bispecifics
Shares Bispecific antibodies, Antibody-drug conjugate (ADC).
- IdeaUse the brain's own transport door to carry antibody drugs across
Shares Bispecific antibodies, Antibody-drug conjugate (ADC).
- InstitutionNational Medical Products Administration / Center for Drug Evaluation
Shares Bispecific antibodies, Antibody-drug conjugate (ADC).
- InstitutionChinese Society of Clinical Oncology
Shares Bispecific antibodies, Antibody-drug conjugate (ADC).
- TermAntibody
Shares Bispecific antibodies, Antibody-drug conjugate (ADC).
- TechnologyBispecific ADC
Shares Bispecific antibodies, Antibody-drug conjugate (ADC).